What do we know about managing Dupuytren’s Disease cost-effectively?
Background: Dupuytren’s disease (DD) is a common and progressive, fibroproliferative disorder of the palmar and digital fascia of the hand. Various treatments have been recommended for advanced disease or to retard progression of early disease and to prevent deterioration of the finger contracture and quality of life. Recent studies have tried to evaluate the clinical and cost-effectiveness of therapies for DD, but there is currently no systematic assessment and appraisal ...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, pdf, 520.9KB)
- Publisher copy:
- Copyright holder:
- Dritsaki et al
- Copyright date:
- © The Author(s). 2018. Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.
- CC Attribution (CC BY)